Chrysomycins, Anti-Tuberculosis C-Glycoside Polyketides from Streptomyces sp. MS751
Jiaming Yu,Hui Guo,Jing Zhang,Jiansen Hu,Hongtao He,Caixia Chen,Na Yang,Fan Yang,Zexu Lin,Huanqin Dai,Liming Ouyang,Cuihua Liu,Xiaoguang Lei,Lixin Zhang,Guoliang Zhu,Fuhang Song
DOI: https://doi.org/10.3390/md22060259
2024-06-04
Marine Drugs
Abstract:A new dimeric C-glycoside polyketide chrysomycin F (1), along with four new monomeric compounds, chrysomycins G (2), H (3), I (4), J (5), as well as three known analogues, chrysomycins A (6), B (7), and C (8), were isolated and characterised from a strain of Streptomyces sp. obtained from a sediment sample collected from the South China Sea. Their structures were determined by detailed spectroscopic analysis. Chrysomycin F contains two diastereomers, whose structures were further elucidated by a biomimetic [2 + 2] photodimerisation of chrysomycin A. Chrysomycins B and C showed potent anti-tuberculosis activity against both wild-type Mycobacterium tuberculosis and a number of clinically isolated MDR M. tuberculosis strains.
pharmacology & pharmacy,chemistry, medicinal